Abstract:HIV infection continues to spread throughout the world without any end insight, and is still the fastest increasing cause of mortality. The majority of HIV-infected patients have HIV-associated oral mucosal lesions at different stages of the disease. In many patients, oral lesions could be the first sign of their HIV infection. Therefore, knowledge of HIV infection has become a critically important requirement for professionals responsible for oral health care delivery and early detection of HIV infection. Oral candidiasis (OC), hairy leukoplakia (HL), and Kaposi sarcoma (KS) are the most common oral lesions strongly associated with HIV infection. Both pseudomembranous and erythematous OC occur in over 95% of HIV-infected patients throughout the oral cavity, highly related to a reversed CD4/CD8 cell ratio. Attached gingiva would be a unique site of OC, only occurring in HIV-infected patients. Because of decreased gastric acid secretion in most HIV-infected patients, fluconazole, the antifungal drug that can be absorbed easily despite the gastric pH change, would be the best choice for systemic antifungal treatment. HL primarily occurs in HIV-infected male patients on the lateral border of the tongue. However, similar-appearing changes can also occur in HIV-negative persons. HL is not related to precancerous leukoplakia or dysplasia. Our latest study indicated that the infection of Epstein-Barr virus (EBV) might not be the definitive criteria for the diagnosis of HL and that the reciprocal activation of EBV and HIV within the epithelium may be the critical event in the development of HL. Our study demonstrated that CD4-bearing oral mucosal Langerhans cells (LC) could be the target of HIV infection, the effector to alter LC number and its antigen processing capability, as well as the vector to pass the virus to submucosal memory T cells, which would be responsible for the second pathway of HIV transmission through mucosal contact with HIV. HIV-associated depletion of LC would lead to impairment of the oral mucosal surveillant system, resulting in opportunistic oral mucosal lesions, such as OC and HL. KS has been the most common tumor associated with HIV infection and has been one of the AIDS defining diseases. The latest study indicated that this tumor is related to opportunistic infection of human herpes simplex virus 8. Because of its reactive type nature clinically and histologically, KS has now been considered a pseudomalignancy. Intralesional injection of cytotoxic drugs has been effective in treatment. Since HIV-infected patients have demonstrated a higher propensity for developing allergic and adverse reactions to antibiotics, bleeding tendency and slow wound healing after dental surgery, decreased levels of neutrophil counts, and xerostomia, a modified dental therapy would be essential for management of HIV-infected dental patients. In addition, concerns about HIV transmission from patient to dentist, dentist to patient, and between patients should be clarified.

[Clinical and research advances in oral AIDS]

Progress on study on oral lesions in patients with AIDS]

Kaposi’s Sarcoma Manifested As Lower Gastrointestinal Bleeding in a HIV/HBV-co-infected Liver Cirrhosis Patient: A Case Report

Case Series of HIV-Associated Oral Lesions Across Different Clinical Stages in People Living with HIV

Oral manifestations of HIV: Can they be an indicator of disease severity? (A systematic review)

Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients

HIV-Related Oral Mucosa Lesions: A Cross-Sectional Study on a Cohort of Italian Patients

Human immunodeficiency virus induced oral candidiasis

Case Series of HIV-Associated Oral Lesions Among Antiretroviral-Naive Patients During the COVID-19 Pandemic

Research Progress of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome-related Oral Diseases

Hiv Diagnosis Due To Kaposi ́S Sarcoma Lesion In The Oral Cavity: Case Report.

Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients

Is human immunodeficiency virus (HIV) stage an independent risk factor for altering the periodontal status of HIV-positive patients? A South African study

Oral health in Australian HIV patients since the advent of combination antiretroviral therapy

Alterations in the oral microbiome in HIV infection: causes, effects and potential interventions

Knowledge, attitudes and practices of oral health care workers in Lesotho regarding the management of patients with oral manifestations of HIV/AIDS

Clinical Oral Condition Analysis and the Influence of Highly Active Antiretroviral Therapy on Human Salivary Microbial Community Diversity in HIV-Infected/AIDS Patients

Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance

Malignancies in HIV-Infected and AIDS Patients.

Relationship of oral candidiasis with salivary lysozyme and lactoferrin in HIV-positive patients: a systematic review

Oropharyngeal Candida Colonization in Human Immunodeficiency Virus Infected Patients